Our previous research indicated that OAS1, OAS2, OAS3 and OASL were all identified as hub genes from the protein-protein interaction network of differentially expressed genes between the trastuzumab-resistant gastric cancer and control groups [11]. This evidence concerns the gene OAS3 and gastric cancer.